Hassan H Ramadan1, Andrew M Terrell. 1. Department of Otolaryngology, West Virginia University School of Medicine, PO Box 9200, Morgantown, WV 26506-9200, USA.
Abstract
OBJECTIVES: Adenoidectomy is the first step in the surgical management of children with chronic rhinosinusitis (CRS). Adenoidectomy, however, is only effective in half of these children. Although endoscopic sinus surgery is effective for CRS, there is concern for facial growth retardation and major complications. We propose that balloon catheter sinuplasty (BCS) is a minimally invasive, effective procedure in the treatment of pediatric CRS. METHODS: We undertook a nonrandomized, controlled, prospective review of children with failed medical management of CRS who underwent BCS or adenoidectomy. Outcomes were assessed at 1 year of follow-up and were based on SN-5 scores and the need for revision surgery. RESULTS: Forty-nine children who satisfied the inclusion criteria were reviewed. Thirty of the children had BCS. The age range was 4 to 11 years (mean, 7.7 years), and the mean computed tomography score (Lund-Mackay system) was 7.5. Twenty-four of the 30 patients (80%) who underwent BCS showed improvement of their symptoms after 12 months of follow-up, compared with 10 of the 19 patients (52.6%) who underwent adenoidectomy (p < 0.05). A multivariate analysis using logistic regression analysis with age, sex, asthma, and computed tomography score as covariables showed that BCS was also more effective than adenoidectomy in older children. None of the other variables showed statistical significance. CONCLUSIONS: Balloon catheter sinuplasty offers a procedure that is more effective than adenoidectomy and less invasive than endoscopic sinus surgery in the treatment of pediatric CRS.
OBJECTIVES: Adenoidectomy is the first step in the surgical management of children with chronic rhinosinusitis (CRS). Adenoidectomy, however, is only effective in half of these children. Although endoscopic sinus surgery is effective for CRS, there is concern for facial growth retardation and major complications. We propose that balloon catheter sinuplasty (BCS) is a minimally invasive, effective procedure in the treatment of pediatric CRS. METHODS: We undertook a nonrandomized, controlled, prospective review of children with failed medical management of CRS who underwent BCS or adenoidectomy. Outcomes were assessed at 1 year of follow-up and were based on SN-5 scores and the need for revision surgery. RESULTS: Forty-nine children who satisfied the inclusion criteria were reviewed. Thirty of the children had BCS. The age range was 4 to 11 years (mean, 7.7 years), and the mean computed tomography score (Lund-Mackay system) was 7.5. Twenty-four of the 30 patients (80%) who underwent BCS showed improvement of their symptoms after 12 months of follow-up, compared with 10 of the 19 patients (52.6%) who underwent adenoidectomy (p < 0.05). A multivariate analysis using logistic regression analysis with age, sex, asthma, and computed tomography score as covariables showed that BCS was also more effective than adenoidectomy in older children. None of the other variables showed statistical significance. CONCLUSIONS: Balloon catheter sinuplasty offers a procedure that is more effective than adenoidectomy and less invasive than endoscopic sinus surgery in the treatment of pediatric CRS.
Authors: Elisabeth H Ference; Madeline Graber; David Conley; Rakesh K Chandra; Bruce K Tan; Charlesnika Evans; Melissa Pynnonen; Stephanie S Smith Journal: Laryngoscope Date: 2014-09-02 Impact factor: 3.325
Authors: Anni Koskinen; Matti Penttilä; Jyri Myller; Sari Hammarén-Malmi; Juha Silvola; Tari Haahtela; Maija Hytönen; Sanna Toppila-Salmi Journal: Am J Rhinol Allergy Date: 2012 Nov-Dec Impact factor: 2.467
Authors: Prasad John Thottam; Chistopher M Metz; Monica C Kieu; James Dworkin; Janardhan Jagini; Johnathan N Bangiyev; Deepak Mehta Journal: Indian J Otolaryngol Head Neck Surg Date: 2015-02-12
Authors: Zachary M Soler; Jeffrey S Rosenbloom; Douglas Skarada; Michael Gutman; Mark J Hoy; Shaun A Nguyen Journal: Int Forum Allergy Rhinol Date: 2016-11-26 Impact factor: 3.858